In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Enavogliflozin Drug Master File in Korea (Enavogliflozin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Enavogliflozin. The MFDS reviews the Enavogliflozin KDMF as part of the drug registration process and uses the information provided in the Enavogliflozin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Enavogliflozin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Enavogliflozin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Enavogliflozin suppliers with KDMF on PharmaCompass.